Insider Trades124 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | Sell | NUVL | Henry E. Pelish | Chief Scientific Officer | 2,111 | $123.81 | $9.8B | -0.02% | +74.27% | $261.4K | -3.22% | 10b5-1 | Sell Now |
| Jul 6, 2026 | Sell | NUVL | James Richard Porter | President and CEO | 60,000 | $71.33 | $9.8B | -0.02% | +74.27% | $4.3M | +0.00% | 10b5-1 | Sell Now |
| Jul 1, 2026 | Sell | NUVL | Alexandra Balcom | Chief Financial Officer | 22,860 | $68.42 | $9.8B | -0.02% | +74.27% | $1.6M | +0.00% | 10b5-1 | Sell Now |
| Jul 1, 2026 | Sell | NUVL | Darlene Noci | Chief Development Officer | 46,000 | $87.35 | $9.8B | -0.02% | +74.27% | $4.0M | +0.00% | 10b5-1 | Sell Now |
| Jun 29, 2026 | Sell | NUVL | Darlene Noci | Chief Development Officer | 11,000 | $75.68 | $9.8B | -0.02% | +74.27% | $832.5K | +0.00% | 10b5-1 | Sell Now |
| Jun 9, 2026 | Sell | NUVL | Darlene Noci | Chief Development Officer | 40,000 | $66.20 | $9.8B | -0.02% | +74.27% | $2.6M | +0.00% | 10b5-1 | Sell Now |
| Jun 8, 2026 | Sell | NUVL | James Richard Porter | President and CEO | 60,000 | $53.73 | $9.8B | -0.02% | +74.27% | $3.2M | +0.00% | 10b5-1 | Sell Now |
| Jun 1, 2026 | Sell | NUVL | Alexandra Balcom | Chief Financial Officer | 22,860 | $52.79 | $9.8B | -0.02% | +74.27% | $1.2M | +0.00% | 10b5-1 | Sell Now |
| May 28, 2026 | Sell | NUVL | Deborah Ann Miller | Chief Legal Officer | 11,000 | $57.36 | $9.8B | -0.02% | +74.27% | $631.0K | +0.00% | 10b5-1 | Sell Now |
| May 28, 2026 | Sell | NUVL | Darlene Noci | Chief Development Officer | 11,000 | $67.83 | $9.8B | -0.02% | +74.27% | $746.1K | +0.00% | 10b5-1 | Sell Now |
| May 4, 2026 | Sell | NUVL | James Richard Porter | President and CEO | 60,000 | $60.31 | $9.8B | -0.02% | +74.27% | $3.6M | +0.00% | 10b5-1 | Sell Now |
| May 1, 2026 | Sell | NUVL | Alexandra Balcom | Chief Financial Officer | 22,860 | $51.13 | $9.8B | -0.02% | +74.27% | $1.2M | +0.00% | 10b5-1 | Sell Now |
| Apr 30, 2026 | Sell | NUVL | Deborah Ann Miller | Chief Legal Officer | 11,000 | $53.05 | $9.8B | -0.02% | +74.27% | $583.6K | +0.00% | 10b5-1 | Sell Now |
| Apr 29, 2026 | Sell | NUVL | Darlene Noci | Chief Development Officer | 11,000 | $63.70 | $9.8B | -0.02% | +74.27% | $700.7K | +0.00% | 10b5-1 | Sell Now |
| Apr 9, 2026 | Sell | NUVL | Henry E. Pelish | Chief Scientific Officer | 6,186 | $66.17 | $9.8B | -0.02% | +74.27% | $409.3K | +0.00% | 10b5-1 | Sell Now |
| Apr 6, 2026 | Sell | NUVL | James Richard Porter | President and CEO | 60,000 | $63.77 | $9.8B | -0.02% | +74.27% | $3.8M | +0.00% | 10b5-1 | Sell Now |
| Apr 1, 2026 | Sell | NUVL | Alexandra Balcom | Chief Financial Officer | 22,860 | $53.14 | $9.8B | -0.02% | +74.27% | $1.2M | +0.00% | 10b5-1 | Sell Now |
| Mar 30, 2026 | Sell | NUVL | Darlene Noci | Chief Development Officer | 11,000 | $62.83 | $9.8B | -0.02% | +74.27% | $691.1K | +0.00% | 10b5-1 | Sell Now |
| Mar 26, 2026 | Sell | NUVL | Deborah Ann Miller | Chief Legal Officer | 11,000 | $52.81 | $9.8B | -0.02% | +74.27% | $580.9K | +0.00% | 10b5-1 | Sell Now |
| Mar 24, 2026 | Sell | NUVL | Alexandra Balcom | Chief Financial Officer | 36,560 | $67.81 | $9.8B | -0.02% | +74.27% | $2.5M | -2.05% | 10b5-1 | Sell Now |
| Mar 12, 2026 | Sell | NUVL | Henry E. Pelish | Chief Scientific Officer | 52,424 | $76.09 | $9.8B | -0.02% | +74.27% | $4.0M | -2.05% | 10b5-1 | Sell Now |
| Mar 6, 2026 | Sell | NUVL | James Richard Porter | President and CEO | 60,000 | $63.42 | $9.8B | -0.02% | +74.27% | $3.8M | +0.00% | 10b5-1 | Sell Now |
| Feb 26, 2026 | Sell | NUVL | Deborah Ann Miller | Chief Legal Officer | 11,000 | $54.97 | $9.8B | -0.02% | +74.27% | $604.7K | +0.00% | 10b5-1 | Sell Now |
| Feb 26, 2026 | Sell | NUVL | Darlene Noci | Chief Development Officer | 11,000 | $65.44 | $9.8B | -0.02% | +74.27% | $719.9K | +0.00% | 10b5-1 | Sell Now |
| Jan 29, 2026 | Sell | NUVL | Darlene Noci | Chief Development Officer | 11,000 | $64.96 | $9.8B | -0.02% | +74.27% | $714.6K | +0.00% | 10b5-1 | Sell Now |
| Jan 21, 2026 | Sell | NUVL | Deborah Ann Miller | Chief Legal Officer | 30,000 | $69.00 | $9.8B | -0.02% | +74.27% | $2.1M | +0.00% | 10b5-1 | Sell Now |
| Jan 5, 2026 | Sell | NUVL | Henry E. Pelish | Chief Scientific Officer | 5,160 | $97.24 | $9.8B | -0.02% | +74.27% | $501.8K | -1.03% | 10b5-1 | Sell Now |
| Jan 5, 2026 | Sell | NUVL | Deborah Ann Miller | Chief Legal Officer | 6,952 | $97.26 | $9.8B | -0.02% | +74.27% | $676.2K | -2.06% | 10b5-1 | Sell Now |
| Jan 5, 2026 | Sell | NUVL | Alexandra Balcom | Chief Financial Officer | 7,417 | $97.25 | $9.8B | -0.02% | +74.27% | $721.3K | -1.20% | 10b5-1 | Sell Now |
| Jan 5, 2026 | Sell | NUVL | Christopher Durant Turner | Chief Medical Officer | 7,417 | $97.25 | $9.8B | -0.02% | +74.27% | $721.3K | -1.72% | 10b5-1 | Sell Now |
| Jan 5, 2026 | Sell | NUVL | Darlene Noci | Chief Development Officer | 7,417 | $97.25 | $9.8B | -0.02% | +74.27% | $721.3K | -2.25% | 10b5-1 | Sell Now |
| Jan 5, 2026 | Sell | NUVL | James Richard Porter | President and CEO | 27,433 | $97.26 | $9.8B | -0.02% | +74.27% | $2.7M | -1.31% | 10b5-1 | Sell Now |
| Jan 2, 2026 | Sell | NUVL | Deborah Ann Miller | Chief Legal Officer | 20,000 | $59.72 | $9.8B | -0.02% | +74.27% | $1.2M | +0.00% | 10b5-1 | Sell Now |
| Dec 30, 2025 | Sell | NUVL | Darlene Noci | Chief Development Officer | 8,000 | $63.95 | $9.8B | -0.02% | +74.27% | $511.6K | +0.00% | 10b5-1 | Sell Now |
| Dec 22, 2025 | Buy | NUVL | Henry E. Pelish | Chief Scientific Officer | 5,085 | $1.08 | $9.8B | -0.02% | +74.27% | $5.5K | +7.71% | — | Sell Now |
| Dec 22, 2025 | Buy | NUVL | Alexandra Balcom | Chief Financial Officer | 34,500 | $1.08 | $9.8B | -0.02% | +74.27% | $37.3K | +15.95% | — | Sell Now |
| Dec 19, 2025 | Buy | NUVL | James Richard Porter | President and CEO | 57,000 | $0.65 | $9.8B | -0.02% | +74.27% | $37.0K | +7.52% | — | Sell Now |
| Dec 8, 2025 | Sell | NUVL | Alexandra Balcom | Chief Financial Officer | 7,084 | $110.32 | $9.8B | -0.02% | +74.27% | $781.5K | -6.08% | 10b5-1 | Sell Now |
| Nov 28, 2025 | Sell | NUVL | Darlene Noci | Chief Development Officer | 8,000 | $68.21 | $9.8B | -0.02% | +74.27% | $545.7K | +0.00% | 10b5-1 | Sell Now |
| Nov 17, 2025 | Sell | NUVL | Deborah Ann Miller | Chief Legal Officer | 48,400 | $56.19 | $9.8B | -0.02% | +74.27% | $2.7M | +0.00% | 10b5-1 | Sell Now |
| Nov 17, 2025 | Sell | NUVL | Alexandra Balcom | Chief Financial Officer | 41,458 | $75.13 | $9.8B | -0.02% | +74.27% | $3.1M | +0.00% | 10b5-1 | Sell Now |
| Oct 30, 2025 | Sell | NUVL | Darlene Noci | Chief Development Officer | 8,000 | $65.38 | $9.8B | -0.02% | +74.27% | $523.1K | +0.00% | 10b5-1 | Sell Now |
| Oct 30, 2025 | Sell | NUVL | Deborah Ann Miller | Chief Legal Officer | 43,600 | $55.03 | $9.8B | -0.02% | +74.27% | $2.4M | +0.00% | 10b5-1 | Sell Now |
| Oct 20, 2025 | Sell | NUVL | Deborah Ann Miller | Chief Legal Officer | 10,000 | $50.90 | $9.8B | -0.02% | +74.27% | $509.0K | +0.00% | 10b5-1 | Sell Now |
| Oct 16, 2025 | Sell | NUVL | James Richard Porter | President and CEO | 54,000 | $54.78 | $9.8B | -0.02% | +74.27% | $3.0M | +0.00% | 10b5-1 | Sell Now |
| Oct 15, 2025 | Sell | NUVL | Alexandra Balcom | Chief Financial Officer | 3,366 | $52.25 | $9.8B | -0.02% | +74.27% | $175.9K | +0.00% | 10b5-1 | Sell Now |
| Oct 15, 2025 | Sell | NUVL | Henry E. Pelish | Chief Scientific Officer | 28,410 | $62.56 | $9.8B | -0.02% | +74.27% | $1.8M | +0.00% | 10b5-1 | Sell Now |
| Oct 15, 2025 | Sell | NUVL | Deborah Ann Miller | Chief Legal Officer | 56,000 | $48.81 | $9.8B | -0.02% | +74.27% | $2.7M | +0.00% | 10b5-1 | Sell Now |
| Oct 13, 2025 | Sell | NUVL | Henry E. Pelish | Chief Scientific Officer | 20,140 | $61.32 | $9.8B | -0.02% | +74.27% | $1.2M | +0.00% | 10b5-1 | Sell Now |
| Oct 13, 2025 | Sell | NUVL | Alexandra Balcom | Chief Financial Officer | 80,000 | $52.11 | $9.8B | -0.02% | +74.27% | $4.2M | +0.00% | 10b5-1 | Sell Now |
| Oct 1, 2025 | Sell | NUVL | Alexandra Balcom | Chief Financial Officer | 40,000 | $47.15 | $9.8B | -0.02% | +74.27% | $1.9M | +0.00% | 10b5-1 | Sell Now |
| Sep 29, 2025 | Sell | NUVL | Darlene Noci | Chief Development Officer | 8,000 | $55.46 | $9.8B | -0.02% | +74.27% | $443.7K | +0.00% | 10b5-1 | Sell Now |
| Sep 29, 2025 | Sell | NUVL | Alexandra Balcom | Chief Financial Officer | 55,176 | $45.97 | $9.8B | -0.02% | +74.27% | $2.5M | +0.00% | 10b5-1 | Sell Now |
| Sep 15, 2025 | Sell | NUVL | James Richard Porter | President and CEO | 54,000 | $49.00 | $9.8B | -0.02% | +74.27% | $2.6M | +0.00% | 10b5-1 | Sell Now |
| Sep 10, 2025 | Sell | NUVL | Henry E. Pelish | Chief Scientific Officer | 7,450 | $52.89 | $9.8B | -0.02% | +74.27% | $394.0K | +0.00% | 10b5-1 | Sell Now |
| Aug 29, 2025 | Buy | NUVL | Henry E. Pelish | Chief Scientific Officer | 5,007 | $1.00 | $9.8B | -0.02% | +74.27% | $5.0K | +3.88% | — | Sell Now |
| Aug 25, 2025 | Sell | NUVL | Darlene Noci | Chief Development Officer | 8,000 | $51.24 | $9.8B | -0.02% | +74.27% | $409.9K | +0.00% | 10b5-1 | Sell Now |
| Aug 15, 2025 | Sell | NUVL | James Richard Porter | President and CEO | 54,000 | $47.17 | $9.8B | -0.02% | +74.27% | $2.5M | +0.00% | 10b5-1 | Sell Now |
| Aug 7, 2025 | Sell | NUVL | Henry E. Pelish | Chief Scientific Officer | 11,000 | $51.28 | $9.8B | -0.02% | +74.27% | $564.1K | +0.00% | 10b5-1 | Sell Now |
| Jul 30, 2025 | Sell | NUVL | Darlene Noci | Chief Development Officer | 8,000 | $54.10 | $9.8B | -0.02% | +74.27% | $432.8K | +0.00% | 10b5-1 | Sell Now |
| Jul 15, 2025 | Sell | NUVL | Alexandra Balcom | Chief Financial Officer | 40,000 | $51.80 | $9.8B | -0.02% | +74.27% | $2.1M | +0.00% | 10b5-1 | Sell Now |
| Jul 15, 2025 | Sell | NUVL | James Richard Porter | President and CEO | 54,000 | $50.60 | $9.8B | -0.02% | +74.27% | $2.7M | +0.00% | 10b5-1 | Sell Now |
| Jul 9, 2025 | Sell | NUVL | Henry E. Pelish | Chief Scientific Officer | 13,145 | $58.74 | $9.8B | -0.02% | +74.27% | $772.1K | -0.43% | 10b5-1 | Sell Now |
| Jun 27, 2025 | Sell | NUVL | Alexandra Balcom | Chief Financial Officer | 40,000 | $49.48 | $9.8B | -0.02% | +74.27% | $2.0M | +0.00% | 10b5-1 | Sell Now |
| Jun 26, 2025 | Sell | NUVL | Darlene Noci | Chief Development Officer | 8,000 | $53.28 | $9.8B | -0.02% | +74.27% | $426.2K | +0.00% | 10b5-1 | Sell Now |
| Jun 25, 2025 | Sell | NUVL | Henry E. Pelish | Chief Scientific Officer | 21,600 | $54.33 | $9.8B | -0.02% | +74.27% | $1.2M | +0.00% | 10b5-1 | Sell Now |
| Jun 16, 2025 | Sell | NUVL | James Richard Porter | President and CEO | 54,000 | $52.39 | $9.8B | -0.02% | +74.27% | $2.8M | +0.00% | 10b5-1 | Sell Now |
| Jun 6, 2025 | Sell | NUVL | Henry E. Pelish | Chief Scientific Officer | 400 | $54.20 | $9.8B | -0.02% | +74.27% | $21.7K | +0.00% | 10b5-1 | Sell Now |
| May 29, 2025 | Sell | NUVL | Darlene Noci | Chief Development Officer | 8,000 | $46.00 | $9.8B | -0.02% | +74.27% | $368.0K | +0.00% | 10b5-1 | Sell Now |
| May 15, 2025 | Sell | NUVL | James Richard Porter | President and CEO | 54,000 | $48.73 | $9.8B | -0.02% | +74.27% | $2.6M | +0.00% | 10b5-1 | Sell Now |
| Apr 29, 2025 | Sell | NUVL | Darlene Noci | Chief Development Officer | 8,000 | $44.48 | $9.8B | -0.02% | +74.27% | $355.8K | +0.00% | 10b5-1 | Sell Now |
| Apr 15, 2025 | Sell | NUVL | James Richard Porter | President and CEO | 54,000 | $48.40 | $9.8B | -0.02% | +74.27% | $2.6M | +0.00% | 10b5-1 | Sell Now |
| Mar 27, 2025 | Sell | NUVL | Darlene Noci | Chief Development Officer | 8,000 | $45.02 | $9.8B | -0.02% | +74.27% | $360.2K | +0.00% | 10b5-1 | Sell Now |
| Mar 17, 2025 | Sell | NUVL | James Richard Porter | President and CEO | 54,000 | $51.86 | $9.8B | -0.02% | +74.27% | $2.8M | +0.00% | 10b5-1 | Sell Now |
| Mar 6, 2025 | Sell | NUVL | Darlene Noci | Chief Development Officer | 68,000 | $37.16 | $9.8B | -0.02% | +74.27% | $2.5M | +0.00% | 10b5-1 | Sell Now |
| Feb 18, 2025 | Sell | NUVL | James Richard Porter | President and CEO | 54,000 | $53.15 | $9.8B | -0.02% | +74.27% | $2.9M | +0.00% | 10b5-1 | Sell Now |
| Jan 31, 2025 | Buy | NUVL | Henry E. Pelish | Chief Scientific Officer | 3,120 | $0.87 | $9.8B | -0.02% | +74.27% | $2.7K | +5.03% | — | Sell Now |
| Jan 15, 2025 | Sell | NUVL | James Richard Porter | President and CEO | 54,000 | $51.92 | $9.8B | -0.02% | +74.27% | $2.8M | +0.00% | 10b5-1 | Sell Now |
| Jan 6, 2025 | Sell | NUVL | Henry E. Pelish | Chief Scientific Officer | 2,483 | $79.68 | $9.8B | -0.02% | +74.27% | $197.9K | -1.11% | 10b5-1 | Sell Now |
| Jan 6, 2025 | Sell | NUVL | Deborah Ann Miller | Chief Legal Officer | 2,964 | $79.68 | $9.8B | -0.02% | +74.27% | $236.2K | -1.55% | 10b5-1 | Sell Now |
| Jan 6, 2025 | Sell | NUVL | Alexandra Balcom | Chief Financial Officer | 4,016 | $79.68 | $9.8B | -0.02% | +74.27% | $320.0K | -1.73% | 10b5-1 | Sell Now |
| Jan 6, 2025 | Sell | NUVL | Christopher Durant Turner | Chief Medical Officer | 4,016 | $79.68 | $9.8B | -0.02% | +74.27% | $320.0K | -1.71% | 10b5-1 | Sell Now |
| Jan 6, 2025 | Sell | NUVL | Darlene Noci | Chief Development Officer | 4,016 | $79.68 | $9.8B | -0.02% | +74.27% | $320.0K | -2.11% | 10b5-1 | Sell Now |
| Jan 6, 2025 | Sell | NUVL | James Richard Porter | President and CEO | 17,301 | $79.68 | $9.8B | -0.02% | +74.27% | $1.4M | -1.93% | 10b5-1 | Sell Now |
| Dec 19, 2024 | Buy | NUVL | James Richard Porter | President and CEO | 22,000 | $0.65 | $9.8B | -0.02% | +74.27% | $14.3K | +2.92% | — | Sell Now |
| Dec 17, 2024 | Buy | NUVL | Alexandra Balcom | Chief Financial Officer | 13,700 | $4.88 | $9.8B | -0.02% | +74.27% | $66.9K | +3.86% | — | Sell Now |
| Dec 16, 2024 | Buy | NUVL | Henry E. Pelish | Chief Scientific Officer | 10,414 | $0.75 | $9.8B | -0.02% | +74.27% | $7.8K | +13.41% | — | Sell Now |
| Dec 16, 2024 | Sell | NUVL | James Richard Porter | President and CEO | 54,000 | $57.23 | $9.8B | -0.02% | +74.27% | $3.1M | +0.00% | 10b5-1 | Sell Now |
| Nov 29, 2024 | Sell | NUVL | Alexandra Balcom | Chief Financial Officer | 20,000 | $61.82 | $9.8B | -0.02% | +74.27% | $1.2M | +0.00% | 10b5-1 | Sell Now |
| Nov 15, 2024 | Sell | NUVL | James Richard Porter | President and CEO | 54,000 | $57.90 | $9.8B | -0.02% | +74.27% | $3.1M | +0.00% | 10b5-1 | Sell Now |
| Nov 1, 2024 | Sell | NUVL | Darlene Noci | Chief Development Officer | 10,000 | $51.50 | $9.8B | -0.02% | +74.27% | $515.0K | +0.00% | 10b5-1 | Sell Now |
| Oct 31, 2024 | Sell | NUVL | Alexandra Balcom | Chief Financial Officer | 20,000 | $58.52 | $9.8B | -0.02% | +74.27% | $1.2M | +0.00% | 10b5-1 | Sell Now |
| Oct 15, 2024 | Sell | NUVL | James Richard Porter | President and CEO | 54,000 | $65.07 | $9.8B | -0.02% | +74.27% | $3.5M | +0.00% | 10b5-1 | Sell Now |
| Oct 1, 2024 | Sell | NUVL | Darlene Noci | Chief Development Officer | 10,000 | $60.34 | $9.8B | -0.02% | +74.27% | $603.4K | +0.00% | 10b5-1 | Sell Now |
| Sep 30, 2024 | Sell | NUVL | Alexandra Balcom | Chief Financial Officer | 20,000 | $64.46 | $9.8B | -0.02% | +74.27% | $1.3M | +0.00% | 10b5-1 | Sell Now |
| Sep 16, 2024 | Sell | NUVL | Deborah Ann Miller | Chief Legal Officer | 16,000 | $57.70 | $9.8B | -0.02% | +74.27% | $923.2K | +0.00% | 10b5-1 | Sell Now |
| Sep 16, 2024 | Sell | NUVL | Henry E. Pelish | Chief Scientific Officer | 32,795 | $98.92 | $9.8B | -0.02% | +74.27% | $3.2M | -6.21% | 10b5-1 | Sell Now |
| Sep 9, 2024 | Sell | NUVL | Deborah Ann Miller | Chief Legal Officer | 6,000 | $47.54 | $9.8B | -0.02% | +74.27% | $285.2K | +0.00% | 10b5-1 | Sell Now |
| Sep 3, 2024 | Sell | NUVL | Darlene Noci | Chief Development Officer | 10,000 | $51.68 | $9.8B | -0.02% | +74.27% | $516.8K | +0.00% | 10b5-1 | Sell Now |
| Aug 30, 2024 | Sell | NUVL | Alexandra Balcom | Chief Financial Officer | 20,000 | $56.04 | $9.8B | -0.02% | +74.27% | $1.1M | +0.00% | 10b5-1 | Sell Now |
| Aug 23, 2024 | Sell | NUVL | Henry E. Pelish | Chief Scientific Officer | 10,500 | $85.08 | $9.8B | -0.02% | +74.27% | $893.3K | -13.71% | 10b5-1 | Sell Now |
| Aug 23, 2024 | Sell | NUVL | Deborah Ann Miller | Chief Legal Officer | 22,000 | $54.42 | $9.8B | -0.02% | +74.27% | $1.2M | +0.00% | 10b5-1 | Sell Now |
| Aug 8, 2024 | Sell | NUVL | Deborah Ann Miller | Chief Legal Officer | 6,000 | $37.84 | $9.8B | -0.02% | +74.27% | $227.0K | +0.00% | 10b5-1 | Sell Now |
| Aug 1, 2024 | Sell | NUVL | Darlene Noci | Chief Development Officer | 10,000 | $48.08 | $9.8B | -0.02% | +74.27% | $480.8K | +0.00% | 10b5-1 | Sell Now |
| Jul 31, 2024 | Sell | NUVL | Alexandra Balcom | Chief Financial Officer | 20,000 | $53.68 | $9.8B | -0.02% | +74.27% | $1.1M | +0.00% | 10b5-1 | Sell Now |
| Jul 12, 2024 | Sell | NUVL | Deborah Ann Miller | Chief Legal Officer | 12,000 | $54.01 | $9.8B | -0.02% | +74.27% | $648.1K | +0.00% | 10b5-1 | Sell Now |
| Jul 8, 2024 | Sell | NUVL | Deborah Ann Miller | Chief Legal Officer | 6,000 | $40.06 | $9.8B | -0.02% | +74.27% | $240.4K | +0.00% | 10b5-1 | Sell Now |
| Jul 1, 2024 | Sell | NUVL | Darlene Noci | Chief Development Officer | 10,000 | $47.23 | $9.8B | -0.02% | +74.27% | $472.3K | +0.00% | 10b5-1 | Sell Now |
| Jun 28, 2024 | Sell | NUVL | Alexandra Balcom | Chief Financial Officer | 20,000 | $51.64 | $9.8B | -0.02% | +74.27% | $1.0M | +0.00% | 10b5-1 | Sell Now |
| Jun 6, 2024 | Sell | NUVL | Deborah Ann Miller | Chief Legal Officer | 16,000 | $47.41 | $9.8B | -0.02% | +74.27% | $758.5K | +0.00% | 10b5-1 | Sell Now |
| May 2, 2024 | Sell | NUVL | Deborah Ann Miller | Chief Legal Officer | 6,000 | $39.48 | $9.8B | -0.02% | +74.27% | $236.9K | +0.00% | 10b5-1 | Sell Now |
| Apr 4, 2024 | Sell | NUVL | Deborah Ann Miller | Chief Legal Officer | 6,000 | $40.24 | $9.8B | -0.02% | +74.27% | $241.5K | +0.00% | 10b5-1 | Sell Now |
| Mar 28, 2024 | Sell | NUVL | Deborah Ann Miller | Chief Legal Officer | 44,000 | $48.89 | $9.8B | -0.02% | +74.27% | $2.2M | +0.00% | 10b5-1 | Sell Now |
| Mar 22, 2024 | Sell | NUVL | Darlene Noci | Chief Development Officer | 40,000 | $42.63 | $9.8B | -0.02% | +74.27% | $1.7M | +0.00% | 10b5-1 | Sell Now |
| Dec 18, 2023 | Sell | NUVL | Alexandra Balcom | Chief Financial Officer | 60,000 | $38.45 | $9.8B | -0.02% | +74.27% | $2.3M | +0.00% | — | Sell Now |
| Dec 18, 2023 | Sell | NUVL | Darlene Noci | Chief Development Officer | 80,000 | $40.26 | $9.8B | -0.02% | +74.27% | $3.2M | +0.00% | — | Sell Now |
| Dec 18, 2023 | Sell | NUVL | Deborah Ann Miller | Chief Legal Officer | 76,092 | $51.19 | $9.8B | -0.02% | +74.27% | $3.9M | +0.00% | — | Sell Now |
| Nov 1, 2023 | Sell | NUVL | Darlene Noci | Chief Development Officer | 6,000 | $26.87 | $9.8B | -0.02% | +74.27% | $161.2K | +0.00% | 10b5-1 | Sell Now |
| Oct 4, 2023 | Sell | NUVL | Christopher Durant Turner | Chief Medical Officer | 15,990 | $30.46 | $9.8B | -0.02% | +74.27% | $487.1K | +0.00% | 10b5-1 | Sell Now |
| Oct 4, 2023 | Sell | NUVL | Darlene Noci | Chief Development Officer | 40,000 | $30.77 | $9.8B | -0.02% | +74.27% | $1.2M | +0.00% | 10b5-1 | Sell Now |
| Oct 2, 2023 | Sell | NUVL | Darlene Noci | Chief Development Officer | 6,000 | $23.48 | $9.8B | -0.02% | +74.27% | $140.9K | +0.00% | 10b5-1 | Sell Now |
| Sep 15, 2023 | Sell | NUVL | Deborah Ann Miller | Chief Legal Officer | 4,000 | $27.27 | $9.8B | -0.02% | +74.27% | $109.1K | +0.00% | 10b5-1 | Sell Now |
| Sep 1, 2023 | Sell | NUVL | Darlene Noci | Chief Development Officer | 6,000 | $23.82 | $9.8B | -0.02% | +74.27% | $142.9K | +0.00% | 10b5-1 | Sell Now |
| Aug 15, 2023 | Sell | NUVL | Deborah Ann Miller | Chief Legal Officer | 4,000 | $24.77 | $9.8B | -0.02% | +74.27% | $99.1K | +0.00% | 10b5-1 | Sell Now |